Search

everythinglearnresearchcommunity

for

Search:↓

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

PSA can help diagnose high androgen levels in women.

Some common medications can lower PSA levels in 45-year-old German men.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Men with pattern baldness may have a higher risk of prostate issues.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Prostate cancer risk is not linked to blood testosterone levels.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Long-term diabetes is linked to lower prostate cancer risk.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.